Viracta, Neurelis & More: The Latest in San Diego Biotech
Xconomy
DECEMBER 5, 2018
Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy. Let’s get caught up with the latest life sciences news in San Diego. The San Diego biotech is developing therapies for cancers related to the Epstein-Barr virus.
Let's personalize your content